Please ensure Javascript is enabled for purposes of website accessibility

Why Bionano Genomics Stock Rocketed More Than 28% Today

By Joe Tenebruso - Jan 25, 2021 at 4:19PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Analysts are growing more bullish on the genetic testing specialist's growth potential.

What happened

Shares of Bionano Genomics (BNGO -6.55%) furthered their recent gains on Monday. By the close of trading, the genome analysis company's stock price was up 28.4%.

So what 

Bullish analyst remarks have likely contributed to Bionano's recent ascent. Maxim analyst Jason McCarthy reiterated his buy rating on Bionano's shares and boosted his price forecast sevenfold -- from $2 to $14 -- on Friday. 

A person is pointing to an upwardly sloping digital chart.

Bionano Genomics stock rose sharply in recent days. Image source: Getty Images.

McCarthy believes the recent Next-Generation Cytogenomics Symposium -- during which doctors and scientists highlighted the impressive capabilities of its Saphyr optical genome mapping (OGM) system -- helped to demonstrate the "important role" Bionano could serve in the healthcare industry. "Awareness, adoption, and messaging in 2019 and 2020 culminated with a cytogenetics symposium that has opened the eyes of the genomics world to Saphyr, in our view," McCarthy said. 

Now what 

McCarthy expects rising awareness of Saphyr among doctors to fuel adoption and, in turn, Bionano's sales growth. He believes Bionano can maximize its profit opportunity with Saphyr by developing more tests for genetic disorders and other areas, such as prenatal screening. 

Doing so should be more possible now that Bionano has bolstered its cash reserves in recent weeks. Management smartly chose to take advantage of the stock's torrid gains to raise roughly $330 million via share sales, which Bionano can now use to fund its research and development efforts.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bionano Genomics, Inc. Stock Quote
Bionano Genomics, Inc.
BNGO
$1.57 (-6.55%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
328%
 
S&P 500 Returns
116%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.